COMMUNIQUÉS West-GlobeNewswire

Medibio Enters Into an Agreement with Otsuka Pharmaceutical Development & Commercialization, Inc.
08/10/2017
Medibio will leverage its proprietary Digital Mental Health platform to process Otsuka clinical data with the goal of further clarifying the role of biomarker-based, objective measures in management of serious mental [...]
Medtronic Provides Update on Impact from Hurricane Maria
06/10/2017
DUBLIN - October 6, 2017 - Medtronic plc (NYSE: MDT) today provided an update on the impact to its manufacturing and sales operations as a result of Hurricane Maria. All four of the company's business groups have some [...]
MERCK ANNOUNCES SALE OF POXEL EQUITY STAKE
06/10/2017
Press Release Your contact : Merck Constance de Quinsonas +33 6 40 87 79 54 constance.de-quinsonas@merckgroup.com THIS PRESS RELEASE MAY NOT BE DISSEMINATED, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, [...]
MERCK ANNONCE LA CESSION DE SA PARTICIPATION DANS POXEL
06/10/2017
Communiqué de presse Votre contact : Merck Constance de Quinsonas +33 6 40 87 79 54 constance.de-quinsonas@merckgroup.com CE COMMUNIQUE DE PRESSE NE DOIT PAS ETRE DIFFUSE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS D' [...]
VALNEVA : Déclaration d'actions et de droits de vote Septembre 2017
06/10/2017
VALNEVA Déclaration d'actions et de droits de vote - SEPTEMBRE 2017 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
Tecan initiates succession process for the Board of Directors
06/10/2017
Männedorf, Switzerland, October 6, 2017 - The Tecan Group (SIX Swiss Exchange: TECN) announced today that a succession process for the Board of Directors has been initiated. Rolf Classon, born in 1945 and member of the [...]
Karo Pharma AB completes voluntary offer for Weifa ASA
06/10/2017
Karo Pharma AB ("Karo Pharma") has today successfully completed the voluntary offer for Weifa ASA ("Weifa"). Payment of the offer price is being made today to the Weifa shareholders who accepted the voluntary offer and [...]
uniQure Announces FDA Orphan Drug Designation for AMT-130 in Huntington's disease
06/10/2017
~ First Investigational Gene Therapy in Huntington's Disease to Receive Designation ~ LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Oct. 06, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy [...]
CapMan Buyout to divest Oral Hammaslääkärit to Colosseum Dental Group
06/10/2017
CapMan Buyout press release 6 October 2017 at 11.00 a.m. EEST CapMan Buyout to divest Oral Hammaslääkärit to Colosseum Dental Group A group of investors led by CapMan Buyout, including f unds managed by CapMan Buyout, [...]
Virbac : Déclaration d'actions et de droits de vote au 30 Septembre 2017
06/10/2017
DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]
Virbac : Declaration of the number of shares and voting rights as of September 2017, 30.
06/10/2017
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017
06/10/2017
Curetis to Present at Key Investor and Scientific Conferences in the Fourth Quarter 2017 Amsterdam, the Netherlands, and Holzgerlingen, Germany, October 6, 2017 -- published at 08:00 am CET -- Curetis N.V. (the " [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
06/10/2017
FIT Biotech Oy Company release October 6, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Alcon receives CE Mark for first-of-its-kind AutonoMe(TM) preloaded intraocular lens (IOL) delivery system with Clareon® IOL
06/10/2017
AutonoMe (TM) preloaded IOL delivery system provides easy, intuitive control for precise IOL insertion during cataract surgery New Clareon ® IOL in vitro data and early clinical experience to be presented at European [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
06/10/2017
REGULATED INFORMATION GHENT, Belgium, 6 October 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Sanofi : La Cour d'appel ordonne un nouveau procès et annule l'injonction permanente dans le cadre du litige en cours relatif au brevet de Praluent® (alirocumab)
05/10/2017
La Cour d'appel ordonne un nouveau procès et annule l'injonction permanente dans le cadre du litige en cours relatif au brevet de Praluent ® (alirocumab) - Praluent continue d'être accessible aux patients aux États-Unis [...]
Sanofi : Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent® (alirocumab)
05/10/2017
Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent ® (alirocumab) - Praluent continues to be available to patients in the U.S. - Paris, France and Tarrytown, N. [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 septembre 2017
05/10/2017
Nombre total de droits de vote et d'actions composant le capital social au 30 septembre 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2017
05/10/2017
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]

Pages